1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow amonafide: new trials by email Literature Review of amonafide trials Research Report on amonafide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study Daunorubicin and Cytarabine, Amonafide and Cytarabine - Secondary Acute Myeloid Leukemia (Secondary AML, sAML) | Phase 3 | Unknown | Antisoma Research | 420 | 2007-06-01 | 2010-10-13 |
Leukemia (1) · Lymphatic Diseases (1)
Argentina (1) · Australia (1) · Austria (1) · Belgium (1) · Canada (1) · Chile (1) · Czechia (1) · Ecuador (1) · Estonia (1) · France (1) · Germany (1) · Hungary (1) · Israel (1) · Italy (1) · Poland (1)